Development of a steroidogenic factor 1/Cre transgenic mouse line

Nathan C Bingham1, Sunita Verma-Kurvari, Luis F Parada

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8857, USA.

Genesis (New York, N.Y. : 2000)
|August 29, 2006
PubMed

Insights

This study introduces a new tool using bacterial artificial chromosome (BAC) transgenesis to target Cre recombinase expression. This BAC enables gene disruption in specific tissues expressing steroidogenic factor 1 (SF-1).

Area of Science:

  • Genetics
  • Molecular Biology
  • Endocrinology

Background:

  • The Cre-loxP system allows for targeted gene disruption.
  • Developing cell-type-specific Cre expression is crucial for genetic studies.
  • Global gene knockouts can cause lethality or off-target effects.

Purpose of the Study:

  • To create a transgenic tool for targeted gene inactivation.
  • To direct Cre recombinase expression to tissues expressing steroidogenic factor 1 (SF-1).

Main Methods:

  • Utilized bacterial artificial chromosome (BAC) transgenesis.
  • Developed an SF-1 BAC transgene to drive Cre expression.

Main Results:

  • The SF-1 BAC successfully directed Cre expression to specific tissues.
  • Expression was observed in gonads, adrenal cortex, anterior pituitary, spleen, and ventromedial hypothalamus.
  • Confirmed SF-1 BAC accurately reflects SF-1 expression patterns.

Conclusions:

  • The SF-1 BAC transgene is a valuable tool for researchers.
  • Enables targeted gene inactivation in SF-1 expressing cells.
  • Facilitates studies on the function of genes in these specific tissues.

Related Concept Videos